RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1[alpha] and inhibition phosphorylation of AKT and mTOR.

Details

Language :

English

ISSN :

03445704

Volume :

69

Issue :

6

Database :

Academic Search Index

Journal :

Cancer Chemotherapy & Pharmacology

Publication Type :

Academic Journal

Accession number :

104454300

Full Text :

https://doi.org/10.1007/s00280-012-1873-3